Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi-directionally convert into cancer stem cells

International Journal of Oncology

Volumn 46, Issue 3, 2015, Pages 1099-1108

  Pozza, Elisa Dalla ^a   Dando, Ilaria ^a   Biondani, Giulia ^a   Brandi, Jessica ^a   Costanzo, Chiara ^a   Zoratti, Elisa ^b   Fassan, Matteo ^b   Boschi, Federico ^a   Melisi, Davide ^c   Cecconi, Daniela ^a   Scupoli, Maria Teresa ^b   Scarpa, Aldo ^b   Palmieri, Marta ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

Author keywords

Cancer stem cell; Chemotherapy resistance; Metastasis; Pancreatic ductal adenocarcinoma

Indexed keywords

CD44V6 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; EVEROLIMUS; GEMCITABINE; SORAFENIB; TIPIFARNIB; UVOMORULIN; ZOLEDRONIC ACID; TUMOR MARKER;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CARCINOMA CELL; CELL AGGREGATION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84921917325     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2796     Document Type: Article

References (33)

1. Bünger S, Barow M, Thorns C, et al: Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue. Eur Surg Res 49: 88-98, 2012.
2. Rasheed ZA and Matsui W: Biological and clinical relevance of stem cells in pancreatic adenocarcinoma. J Gastroenterol Hepatol 27 (Suppl 2): S15-S18, 2012.
3. Marjanovic ND, Weinberg RA and Chaffer CL: Cell plasticity and heterogeneity in cancer. Clin Chem 59: 168-179, 2013.
4. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997.
5. Gaviraghi M, Tunici P, Valensin S, et al: Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Biosci Rep 31: 45-55, 2011.
6. Kure S, Matsuda Y, Hagio M, Ueda J, Naito Z and Ishiwata T: Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Int J Oncol 41: 1314-1324, 2012.
7. Rhim AD, Mirek ET, Aiello NM, et al: EMT and dissemination precede pancreatic tumor formation. Cell 148: 349-361, 2012.
8. Yang G, Quan Y, Wang W, et al: Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br J Cancer 106: 1512-1519, 2012.
9. Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284, 2005.
10. Feng Y, Dai X, Li X, et al: EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Prolif 45: 413-419, 2012.
11. Ponti D, Costa A, Zaffaroni N, et al: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005.
12. Tsai LL, Yu CC, Chang YC, Yu CH and Chou MY: Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med 40: 621-628, 2011.
13. Chaffer CL, Brueckmann I, Scheel C, et al: Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 108: 7950-7955, 2011.
14. Varga J, De Oliveira T and Greten FR: The architect who never sleeps: tumor-induced plasticity. FEBS Lett 588: 2422-2427, 2014.
15. Melisi D, Ishiyama S, Sclabas GM, et al: LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther 7: 829-840, 2008.
16. Zheng G, Lyons JG, Tan TK, et al: Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 175: 580-591, 2009.
17. Chen SF, Chang YC, Nieh S, Liu CL, Yang CY and Lin YS: Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS One 7: e31864, 2012.
18. Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Ganti AK and Batra SK: Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells. Br J Cancer 111: 486-496, 2014.
19. Shackleton M: Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol 20: 85-92, 2010.
20. Singh AK, Arya RK, Maheshwari S, et al: Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance. Int J Cancer: Feb 22, 2014 (Epub ahead of print).
21. Song J, Chang I, Chen Z, Kang M and Wang CY: Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PLoS One 5: e11456, 2010.
22. Yanamoto S, Kawasaki G, Yamada S, et al: Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol 47: 855-860, 2011.
23. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU and Gallick GE: Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 14: 3629-3637, 2007.
24. Zeng W, Chen X, Ma Y, et al: A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line. Anticancer Res 34: 117-123, 2014.
25. Donadelli M, Costanzo C, Beghelli S, et al: Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim Biophys Acta 1773: 1095-1106, 2007.
26. Piacentini P, Donadelli M, Costanzo C, Moore PS, Palmieri M and Scarpa A: Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. Virchows Arch 448: 797-804, 2006.
27. Moore PS, Sipos B, Orlandini S, et al: Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 439: 798-802, 2001.
28. Niess H, Camaj P, Renner A, et al: Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. Target Oncol: Jun 22, 2014 (Epub ahead of print).
29. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
30. Gemei M, Mirabelli P, Di Noto R, et al: CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Cancer 119: 729-738, 2013.
31. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007.
32. Arpicco S, Lerda C, Dalla Pozza E, et al: Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm 85: 373-380, 2013.
33. Cain JW, Hauptschein RS, Stewart JK, Bagci T, Sahagian GG and Jay DG: Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature technology. Mol Cancer Res 9: 637-647, 2011.